TABLE 1.

Patient Characteristics

Characteristic	n	%	Median	Range	95% CI
Patients^*	26
Sex
Women	12	46.2
Men	14	53.8
Histology
PTC	11	42.3
FTC	13	50
OTC	2	7.7
UICC TNM (33)
pT1	4	15.4
pT2	7	27
pT3	9	34.6
pT4	3	11.5
pTx	3	11.5
pN0	5	19.2
pN1	7	27
pNx	14	53.8
cM0	5	19.2
cM1	16	61.5
cMx	5	19.2
PUL	5	19.2
OSS	7	27
OTH	4	15.4
Laboratory analysis
TG^† (ng/mL)			10.1	0.15–10,807
Anti-TG^† (IU/mL)			17.2	<15–230
TSH (μU/mL)			0.1	0.02–2.36
TSH after stimulation (μU/mL)			122	51.8–424.1
TG after stimulation (ng/mL)			61.9	0.46–21,200
8 wk after RAI
TG^†			6.7	0.15–10,780
Anti-TG^†			15.6	<15–238
RAI and PET/CT
GBq of [¹³¹I]iodine			6,023		5,032–6,497
MBq of [¹⁸F]TFB			321		297–342
MBq of [¹⁸F]FDG			326		270–317

↵* Median age was 64.5 y, and range was 38–87.
↵† If measurable.
PTC = papillary thyroid carcinoma; FTC = follicular thyroid carcinoma; OTC = oncocytic carcinoma of thyroid; PUL = pulmonary metastases; OSS = bone metastases; OTH = other-side metastases; anti-TG = antibodies against thyroglobulin.